466 related articles for article (PubMed ID: 27842171)
1. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
[TBL] [Abstract][Full Text] [Related]
2. National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey.
Salami JA; Warraich HJ; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Katzen BT; Lloyd-Jones D; Krumholz HM; Nasir K
J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358195
[TBL] [Abstract][Full Text] [Related]
3. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
Lin SY; Baumann K; Zhou C; Zhou W; Cuellar AE; Xue H
JAMA Netw Open; 2021 Nov; 4(11):e2135371. PubMed ID: 34807258
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
5. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.
Sumarsono A; Lalani HS; Vaduganathan M; Navar AM; Fonarow GC; Das SR; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):92-96. PubMed ID: 32902560
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
Chen EM; Kombo N; Teng CC; Mruthyunjaya P; Nwanyanwu K; Parikh R
Ophthalmology; 2020 Oct; 127(10):1292-1302. PubMed ID: 32359935
[TBL] [Abstract][Full Text] [Related]
7. Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention.
Ngo-Metzger Q; Zuvekas SH; Bierman AS
J Gen Intern Med; 2018 Aug; 33(8):1317-1323. PubMed ID: 29855861
[TBL] [Abstract][Full Text] [Related]
8. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
[TBL] [Abstract][Full Text] [Related]
10. Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal.
Ngo-Metzger Q; Zuvekas S; Shafer P; Tracer H; Borsky AE; Bierman AS
J Am Board Fam Med; 2019; 32(6):807-817. PubMed ID: 31704749
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy.
Case BC; Bress AP; Kolm P; Philip S; Herrick JS; Granowitz CB; Toth PP; Fan W; Wong ND; Hull M; Weintraub WS
J Clin Lipidol; 2019; 13(5):754-761. PubMed ID: 31427271
[TBL] [Abstract][Full Text] [Related]
12. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
[TBL] [Abstract][Full Text] [Related]
13. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
14. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
Haas JS; Phillips KA; Gerstenberger EP; Seger AC
Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
[TBL] [Abstract][Full Text] [Related]
15. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
[TBL] [Abstract][Full Text] [Related]
16. Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.
Khera R; Valero-Elizondo J; Okunrintemi V; Saxena A; Das SR; de Lemos JA; Krumholz HM; Nasir K
JAMA Cardiol; 2018 Aug; 3(8):729-738. PubMed ID: 29971325
[TBL] [Abstract][Full Text] [Related]
17. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2019 Mar; 4(3):206-213. PubMed ID: 30758506
[TBL] [Abstract][Full Text] [Related]
18. The impact of manufacturer coupon use in the statin market.
Daugherty JB; Maciejewski ML; Farley JF
J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
[TBL] [Abstract][Full Text] [Related]
20. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey.
Salami JA; Valero-Elizondo J; Ogunmoroti O; Spatz ES; Rana JS; Virani SS; Blankstein R; Younus A; Arrieta A; Blaha MJ; Veledar E; Nasir K
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28600400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
